Needle-Free Delivery: Technology and Market 2012-2022
http://www.reportlinker.com/p0788999/Needle-Free-Delivery-Technology-and-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Report Details
The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, the recent years have seen an increase in adoption, driven by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with the pharmaceutical companies entering into partnership with the device developers for using the technology for delivery of the company's drug. Teva Pharmaceuticals is using the Tjet injector system developed by Antares Pharma for delivery of TEV-TROPIN. We expect the pharmaceutical companies to begin developing drugs specifically for use with the needle-free systems, in the near future. According to our latest pharma report - Needle-Free Delivery: Technology and Market 2012-2022 - the global needle-free delivery devices market will be worth $2.1bn by 2016.
Needle-Free Delivery: Technology and Market 2012-2022 report forecasts the size and value of tleading national markets: the US, EU5, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period.
The needle-free delivery technology is advantageous for the drug and device developers as well as the end-users. The various factors backing the adoption of the needle-free devices include, but are not limited to, the ease of use, pain-free delivery, differentiation for product line extensions and life cycle management. However, the market is also faced with challenges of high cost, manufacturing inefficiencies, and reimbursement issues owing to the low cost of traditional delivery using hypodermic needles.
Needle-Free Delivery: Technology and Market 2012-2022 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies and leading products. Discover over 70 tables and charts and two research interviews (shown in the accompanying lists).
Why you should buy Needle-Free Delivery: Technology and Market 2012-2022
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for needle-free delivery devices, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall needle-free delivery devices market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - jet injectors and competing needle-free technology - from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national markets (US, Japan, EU5, India and China), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the needle-free delivery devices market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the needle-free delivery devices market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the needle-free delivery devices market from 2012 onwards
• You will see what will stimulate and restrain the market from 2012
• You will discover the unmet needs in the market, driving the growth from 2012 onwards
• You will view expert opinion from our survey, including two full interview transcripts.
You can order this report today
Anybody with an interest in the needle-free drug/vaccine delivery market should gain valuable information and insight from this new study by Visiongain, which analyses one of the most important sub-sectors of the medical device industry. The needle-free delivery devices market is undergoing many important shifts. You can stay ahead by ordering this report today.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 Overview
1.2 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Needle-Free Delivery
2. Introduction to Needle-Free Delivery of Drug/Vaccines
2.1 What is Needle-Free Technology?
2.1.1 History of Needle-Free Injections (NFI)
2.2 Why the Need for Needle-Free Delivery Technology?
2.2.1 Needle Stick Injury
2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury
2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.3.1 Pain Management
2.3.2 Vaccine Delivery
2.3.2.1 The Global Vaccine Market, 2012-2022
2.3.2.2 Needle-Free Vaccine Delivery
2.3.2.3 Mass Immunisation
2.3.3 Insulin Delivery for Diabetics
2.3.4 Paediatric Injections
2.3.5 Other Uses For Needle-Free Injection Technology
2.4 Advantages and Disadvantages of Needle-Free Injections
2.5 The Needle-Free Delivery Market
2.6 Regulation of the Needle-Free Delivery Market
2.6.1 The US Regulation System
2.6.2 The European Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. The Needle-Free Delivery Devices Market, 2010-2022
3.1 The Needle-Free Delivery Devices Market Overview
3.2 The Needle-Free Injection Market by Segment and Region, 2010
3.2.1 The Needle-Free Delivery Devices Market: Breakdown by Segment, 2010
3.2.2 The Needle-Free Delivery Market: Regional Breakdown, 2010
3.2.3 Regional Market Breakdown, 2010
3.2.3.1 The US Market
3.2.3.2 The EU Market
3.2.3.3 The Japanese Market
3.2.3.4 The Chinese Market
3.2.3.5 The Indian Market
3.3 The Needle Free Delivery Market Forecasts, 2011-2022
3.3.1 The Needle Free Delivery Market Forecasts, 2011-2016
3.3.2 The Needle Free Delivery Market Forecast, 2016-2022
3.4 The Needle-Free Delivery Market Forecasts by Region, 2011-2022
3.4.1 The US, EU and Japanese Markets, 2011-2022
3.4.1.1 The US Market
3.4.1.2 The EU Market
3.4.1.3 The Japanese Market
3.4.2 The Chinese and Indian Markets, 2011-2022
3.4.2.1 The Chinese Market
3.4.2.2 The Indian Market
4. The Jet Injectors: Technology and Market, 2010-2022
4.1 Introduction to Jet Injectors
4.2 Leading Products in the Jet Injectors Market
4.2.1 ZetaJet (Bioject Medical Technologies)
4.2.2 E-Jet 100 (Eurojet Medical)
4.2.3 PharmaJet (PharmaJet)
4.2.4 LectraJet (D'Antonio Consultants International)
4.2.5 Biojector 2000 (Bioject Medical Technologies)
4.2.6 Med-Jet (Medical International Technologies)
4.2.7 VISION/Tjet (Antares Pharma)
4.2.8 Glide System (Glide Pharma)
4.2.9 AdvantaJet (Activa)
4.2.10 J-Tip (National Medical Products)
4.2.11 SQ-Pen (Diabetes Management International)
4.2.12 SUMAVEL DosePro (Zogenix)
4.3 The Jet Injector Device Market, 2010-2022
4.3.1 The Jet Injector Device Market, 2010
4.3.2 The Jet Injectors Market Forecast, 2011-2022
4.3.2.1 Market Forecast for Leading Segments in The Jet Injectors Market, 2011-2016
4.3.2.2 Market Forecast for Leading Segments in The Jet Injectors Market, 2016-2022
4.4 Jet Injectors Development Pipeline
4.4.1 Zeneo (Crossject)
4.4.2 P.L.E.A.S.E. (Pantec Biosolutions)
4.4.3 Jupiter Jet (Bioject Medical Technologies)
4.4.4 Iject (Bioject Medical Technologies)
4.4.4.1 Iject R (Bioject Medical Technologies)
4.4.5 PyroFast (Pervormanc)
4.4.6 Relday (Zogenix)
4.5 Concluding Remarks
5. Competing Needle-Free Technologies, 2010-2022
5.1 Competing Needle-Free Technologies: Introduction
5.1.1 Novel Needle Technology
5.1.1.1 Microneedles
5.1.1.1.1 Solid Microneedles
5.1.1.1.2 Hollow Microneedles
5.1.1.1.3 Drug Microneedles
5.1.1.1.4 Selection of Microneedles
5.1.2 Inhalers
5.1.2.1 Inhalers for Vaccine Delivery
Be the first to review this article
